Klaus Parhofer, University of Munich, Germany, explains how endocrinologists estimate risk of ASCVD and pancreatitis based on TG and other lipid/non-lipid risk factors, address secondary hypertriglyceridaemia, and initiate lifestyle change and drug therapies.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
